|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,448.00 INR | +0.31% |
|
-3.87% | -9.04% |
| 11/03 | Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3% | MT |
| 11/03 | Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences | RE |
EPS & Dividend: Hester Biosciences Limited
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | 6.6 | 10 | 10 | 8 | 6 | 7 |
| Rate of return | 0.71% | 0.52% | 0.37% | 0.53% | 0.43% | 0.56% |
| EPS 2 | 34.29 | 40.47 | 46.22 | 31.3 | 22.2 | 32.31 |
| Distribution rate | 19.2% | 24.7% | 21.6% | 25.6% | 27% | 21.7% |
| Reference price 2 | 925.05 | 1,916.75 | 2,715.30 | 1,520.45 | 1,389.25 | 1,253.90 |
| Nbr of stocks (in thousands) | 8,507 | 8,507 | 8,507 | 8,507 | 8,507 | 8,507 |
| Announcement Date | 04/08/20 | 23/07/21 | 29/07/22 | 23/08/23 | 26/07/24 | 11/07/25 |
1INR in Million2INR
Estimates
Past dividends: Hester Biosciences Limited
| 06/08/2025 | Ex-dividend date - 7 INR | 09:30 am |
Upcoming Events: Hester Biosciences Limited
| 30/05/2026 | Earnings release | Annual 2026 | Day |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 1.8% | 1.99% | 18.15x | 10.74x | 5.66x | |
| -.--% | -.--% | 301.26x | 1.85x | 2.98x | |
| 1.36% | 2.09% | 29.51x | 2.07x | 2.21x | |
| 0.46% | 0.52% | 18.72x | 2.44x | 2.04x | |
| 0.26% | 0.59% | 89.29x | 3.1x | - | |
| 0.95% | 0.95% | 20.8x | 5.46x | 1.73x | |
| -.--% | -.--% | 39.49x | 1.72x | 3.52x | |
| 2.56% | 3.03% | 19.64x | 1.9x | 2.6x | |
| 1% | 1.13% | 37.41x | 1.44x | - | |
| Average | 0.93% | 1.14% | 63.81x | 3.41x | 2.96x | |
| Weighted average by Cap. | 1.34% | 1.54% | 63.39x | 7.64x | 4.63x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition